vs
思佳讯（SWKS）与West Pharmaceutical Services（WST）财务数据对比。点击上方公司名可切换其他公司
思佳讯的季度营收约是West Pharmaceutical Services的1.2倍（$943.7M vs $805.0M），West Pharmaceutical Services净利率更高（16.4% vs 3.8%，领先12.6%），West Pharmaceutical Services同比增速更快（7.5% vs -1.0%），过去两年West Pharmaceutical Services的营收复合增速更高（7.6% vs 2.1%）
思佳讯是总部位于美国加利福尼亚州尔湾的半导体企业，公司股票在纳斯达克全球精选市场挂牌交易，股票代码为SWKS，同时也是标普500指数的成分股之一，在全球射频半导体领域拥有较高市场地位。
美国West Pharmaceutical Services是注射用药品包装及给药系统的设计和制造商，1923年成立，总部位于宾夕法尼亚州埃克斯顿。成立初期主营注射类药物包装用橡胶组件，曾为青霉素和胰岛素生产商提供符合无菌要求的配套产品。
SWKS vs WST — 直观对比
营收规模更大
SWKS
是对方的1.2倍
$805.0M
营收增速更快
WST
高出8.5%
-1.0%
净利率更高
WST
高出12.6%
3.8%
两年增速更快
WST
近两年复合增速
2.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $943.7M | $805.0M |
| 净利润 | $35.6M | $132.1M |
| 毛利率 | 40.8% | 37.8% |
| 营业利润率 | 4.5% | 19.5% |
| 净利率 | 3.8% | 16.4% |
| 营收同比 | -1.0% | 7.5% |
| 净利润同比 | -48.2% | 1.5% |
| 每股收益（稀释后） | $0.24 | $1.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SWKSWST
| Q2 26 | $943.7M | — | ||
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.1B | $805.0M | ||
| Q3 25 | — | $804.6M | ||
| Q2 25 | $965.0M | $766.5M | ||
| Q1 25 | $953.2M | $698.0M | ||
| Q4 24 | $1.1B | $748.8M | ||
| Q3 24 | $1.0B | $746.9M |
净利润SWKSWST
| Q2 26 | $35.6M | — | ||
| Q1 26 | $79.2M | — | ||
| Q4 25 | $141.4M | $132.1M | ||
| Q3 25 | — | $140.0M | ||
| Q2 25 | $105.0M | $131.8M | ||
| Q1 25 | $68.7M | $89.8M | ||
| Q4 24 | $162.0M | $130.1M | ||
| Q3 24 | $60.5M | $136.0M |
毛利率SWKSWST
| Q2 26 | 40.8% | — | ||
| Q1 26 | 41.3% | — | ||
| Q4 25 | 40.7% | 37.8% | ||
| Q3 25 | — | 36.6% | ||
| Q2 25 | 41.6% | 35.7% | ||
| Q1 25 | 41.1% | 33.2% | ||
| Q4 24 | 41.4% | 36.5% | ||
| Q3 24 | 41.9% | 35.4% |
营业利润率SWKSWST
| Q2 26 | 4.5% | — | ||
| Q1 26 | 10.0% | — | ||
| Q4 25 | 10.1% | 19.5% | ||
| Q3 25 | — | 20.8% | ||
| Q2 25 | 11.5% | 20.1% | ||
| Q1 25 | 10.2% | 15.3% | ||
| Q4 24 | 16.9% | 21.3% | ||
| Q3 24 | 5.8% | 21.6% |
净利率SWKSWST
| Q2 26 | 3.8% | — | ||
| Q1 26 | 7.6% | — | ||
| Q4 25 | 12.9% | 16.4% | ||
| Q3 25 | — | 17.4% | ||
| Q2 25 | 10.9% | 17.2% | ||
| Q1 25 | 7.2% | 12.9% | ||
| Q4 24 | 15.2% | 17.4% | ||
| Q3 24 | 5.9% | 18.2% |
每股收益（稀释后）SWKSWST
| Q2 26 | $0.24 | — | ||
| Q1 26 | $0.53 | — | ||
| Q4 25 | $0.95 | $1.82 | ||
| Q3 25 | — | $1.92 | ||
| Q2 25 | $0.70 | $1.82 | ||
| Q1 25 | $0.43 | $1.23 | ||
| Q4 24 | $1.00 | $1.78 | ||
| Q3 24 | $0.36 | $1.85 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $791.3M |
| 总债务越低越好 | — | $202.8M |
| 股东权益账面价值 | $5.8B | $3.2B |
| 总资产 | $7.9B | $4.3B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资SWKSWST
| Q2 26 | — | — | ||
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.4B | $791.3M | ||
| Q3 25 | — | $628.5M | ||
| Q2 25 | $1.3B | $509.7M | ||
| Q1 25 | $1.5B | $404.2M | ||
| Q4 24 | $1.7B | $484.6M | ||
| Q3 24 | $1.6B | $490.9M |
总债务SWKSWST
| Q2 26 | — | — | ||
| Q1 26 | $496.6M | — | ||
| Q4 25 | $496.4M | $202.8M | ||
| Q3 25 | — | $202.7M | ||
| Q2 25 | $496.2M | $202.6M | ||
| Q1 25 | $995.1M | $202.6M | ||
| Q4 24 | $994.7M | $202.6M | ||
| Q3 24 | $994.3M | $202.6M |
股东权益SWKSWST
| Q2 26 | $5.8B | — | ||
| Q1 26 | $5.8B | — | ||
| Q4 25 | $5.8B | $3.2B | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | $5.7B | $2.9B | ||
| Q1 25 | $5.9B | $2.7B | ||
| Q4 24 | $6.4B | $2.7B | ||
| Q3 24 | $6.3B | $2.8B |
总资产SWKSWST
| Q2 26 | $7.9B | — | ||
| Q1 26 | $7.9B | — | ||
| Q4 25 | $7.9B | $4.3B | ||
| Q3 25 | — | $4.1B | ||
| Q2 25 | $7.7B | $4.0B | ||
| Q1 25 | $7.9B | $3.6B | ||
| Q4 24 | $8.3B | $3.6B | ||
| Q3 24 | $8.3B | $3.7B |
负债/权益比SWKSWST
| Q2 26 | — | — | ||
| Q1 26 | 0.09× | — | ||
| Q4 25 | 0.09× | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | 0.09× | 0.07× | ||
| Q1 25 | 0.17× | 0.08× | ||
| Q4 24 | 0.16× | 0.08× | ||
| Q3 24 | 0.16× | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $50.3M | $251.1M |
| 自由现金流经营现金流 - 资本支出 | — | $175.0M |
| 自由现金流率自由现金流/营收 | — | 21.7% |
| 资本支出强度资本支出/营收 | 8.7% | 9.5% |
| 现金转化率经营现金流/净利润 | 1.41× | 1.90× |
| 过去12个月自由现金流最近4个季度 | — | $468.9M |
8季度趋势，按日历期对齐
经营现金流SWKSWST
| Q2 26 | $50.3M | — | ||
| Q1 26 | $395.5M | — | ||
| Q4 25 | $200.0M | $251.1M | ||
| Q3 25 | — | $197.2M | ||
| Q2 25 | $314.2M | $177.1M | ||
| Q1 25 | $409.4M | $129.4M | ||
| Q4 24 | $377.2M | $190.1M | ||
| Q3 24 | $476.1M | $180.1M |
自由现金流SWKSWST
| Q2 26 | — | — | ||
| Q1 26 | $339.0M | — | ||
| Q4 25 | $144.0M | $175.0M | ||
| Q3 25 | — | $133.9M | ||
| Q2 25 | $252.7M | $101.9M | ||
| Q1 25 | $370.9M | $58.1M | ||
| Q4 24 | $338.2M | $85.2M | ||
| Q3 24 | $393.3M | $98.8M |
自由现金流率SWKSWST
| Q2 26 | — | — | ||
| Q1 26 | 32.7% | — | ||
| Q4 25 | 13.1% | 21.7% | ||
| Q3 25 | — | 16.6% | ||
| Q2 25 | 26.2% | 13.3% | ||
| Q1 25 | 38.9% | 8.3% | ||
| Q4 24 | 31.7% | 11.4% | ||
| Q3 24 | 38.4% | 13.2% |
资本支出强度SWKSWST
| Q2 26 | 8.7% | — | ||
| Q1 26 | 5.5% | — | ||
| Q4 25 | 5.1% | 9.5% | ||
| Q3 25 | — | 7.9% | ||
| Q2 25 | 6.4% | 9.8% | ||
| Q1 25 | 4.0% | 10.2% | ||
| Q4 24 | 3.6% | 14.0% | ||
| Q3 24 | 8.1% | 10.9% |
现金转化率SWKSWST
| Q2 26 | 1.41× | — | ||
| Q1 26 | 4.99× | — | ||
| Q4 25 | 1.41× | 1.90× | ||
| Q3 25 | — | 1.41× | ||
| Q2 25 | 2.99× | 1.34× | ||
| Q1 25 | 5.96× | 1.44× | ||
| Q4 24 | 2.33× | 1.46× | ||
| Q3 24 | 7.87× | 1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SWKS
暂无分部数据
WST
| Proprietary Products | $661.8M | 82% |
| Contract Manufactured Products | $143.2M | 18% |
| Affiliated Entity | $3.3M | 0% |
